Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference being held in New York on December 3-5, 2024.
WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference being held in New York on December 3-5, 2024.
|
Piper Sandler 36th Annual Healthcare Conference details: | |
| Meetings: | Presentation and one-on-one meetings |
| Presentation Date: | Tuesday, December 3rd, 2024 |
| Presentation Time: | 12:30 PM ET |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
| Piper Sandler 36th Annual Healthcare Conference details: | |
| 會議： | Presentation and one-on-one meetings |
| 演講日期： | 2024年12月3日，星期二 |
| 演講時間： | 下午12:30 ET |
| 報告人： | 阿莉絲·瑞辛，醫學博士，董事長兼首席執行官 |
| 網絡直播： | 連接 |
For more information regarding one-on-one meetings, please contact your Piper Sandler representative.
有關一對一會議的更多信息，請聯繫您的派傑投資代表。
The live webcast can also be accessed under "Events & Presentations" on the Investors section of the Tectonic website at . Once the conference has concluded, a replay of the webcast will be available on the Company's website for approximately 90 days.
實時網絡廣播也可以在Tectonic網站投資者專區的「事件與演示」中訪問。會議結束後，網絡廣播的重播將在公司網站上提供大約90天。
About Tectonic
關於Tectonic
Tectonic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its proprietary GEODe (GPCRs Engineered for Optimal Discovery) technology platform, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit and follow on LinkedIn.
Tectonic是一家處於臨床階段的生物技術公司，專注於治療蛋白質和抗體的發現與開發，這些蛋白質和抗體可以調節G蛋白偶聯受體（GPCRs）的活性。Tectonic利用其專有的GEODe（優化發現的GPCRs設計）技術平台，專注於開發生物製藥，以克服現有GPCR靶向藥物發現的挑戰，並利用人體來改變疾病的進程。Tectonic關注重大未滿足的醫療需求領域，通常在這些領域治療選擇較少或完全不存在，因爲這些地方新藥有潛力改善患者的生活質量。Tectonic總部位於馬薩諸塞州的沃特敦。更多信息，請訪問並在LinkedIn上關注。
CONTACT: Investors:
Dan Ferry
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
Media:
Kathryn Morris
The Yates Network
kathryn@theyatesnetwork.com
(914) 204-6412
聯繫方式：投資者：
丹·費裏，電話：(617) 430-7576
LifeSci顧問
daniel@lifesciadvisors.com
(617) 430-7576
媒體:
Kathryn Morris
耶茨網絡
kathryn@theyatesnetwork.com
(914) 204-6412
譯文內容由第三人軟體翻譯。
